
GC30257
Bendazaclysine
Also listed as Bendazac L-Lysine
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention
ChemicalCAS81919-14-4MW428.48FormulaC22H28N4O5
- CAS number
- 81919-14-4
- Molecular weight
- 428.48
- Formula
- C22H28N4O5
- Solubility
- Water : ≥ 100 mg/mL (233·38 mM)
- InChIKey
- OCOCFNMFLNFNIA-UHFFFAOYSA-N
- Catalogue number
- GC30257
- Brand
- GLPBIO
Computed properties PubChem CID 10320377 · TPSA 154 Ų · H-bond donors 4 · H-bond acceptors 8
- TPSA
- 154 Ų
- H-bond donors
- 4
- H-bond acceptors
- 8
- Rotatable bonds
- 10
- Heavy atoms
- 31
SMILES C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O.C(CCN)CC(C(=O)O)N
Computed descriptors from PubChem (CID 10320377), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il